Format

Send to

Choose Destination
Drug Discov Today. 2010 Aug;15(15-16):622-9. doi: 10.1016/j.drudis.2010.06.011. Epub 2010 Jun 25.

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.

Author information

1
Department of Medicine & Therapeutics, Chinese University of Hong Kong, Hong Kong, China.

Abstract

The Rho/rho-kinase (ROCK) pathway has an important role in the pathogenesis of several cardiovascular diseases. The activation of ROCK is involved in the regulation of vascular tone, endothelial dysfunction, inflammation and remodeling. The inhibition of ROCK has a beneficial effect in a variety of cardiovascular disorders. Evidence from animal models and from clinical use of ROCK inhibitors, such as Y-27632, fasudil and statins (i.e. pleiotropic effects), supports the hypothesis that ROCK is a potential therapeutic target. This review provides a current understanding of the role of ROCK pathway in the regulation of vascular function and the use of ROCK inhibitors in the treatment of cardiovascular disorders.

PMID:
20601092
PMCID:
PMC3807099
DOI:
10.1016/j.drudis.2010.06.011
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center